Cargando…
A hospital-based cost minimization study of the potential financial impact on the UK health care system of introduction of iron isomaltoside 1000
BACKGROUND: The clinical need to be able to administer high doses of intravenous iron conveniently in a single rapid infusion has been addressed by the recent introduction of ferric carboxymaltose and subsequently iron isomaltoside 1000. Neither requires a test dose. Ferric carboxymaltose can be adm...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3071347/ https://www.ncbi.nlm.nih.gov/pubmed/21479141 http://dx.doi.org/10.2147/TCRM.S17536 |